Scrapie is a disease which occurs naturally in sheep and goats and belongs to a group of neurodegenerative disorders known as transmissible spongiform encephalopathies, or TSEs. There is currently no cure for TSEs, and the causative agent has not yet been identified. Numerous experiments, however, have addressed the pathogenetic process following a TSE infection. In this paper we present a study of the spread of the scrapie agent after intraperitoneal infection of hamsters. The accumulation of TSE-specific amyloid protein, TSE-AP (also known as PrP), was used as a marker for infectivity. The data suggested three points of agent entry into
Introduction
The transmissible spongiform encephalopathies (TSEs) are a group of neurodegenerative diseases affecting a wide range of hosts. Scrapie in sheep, bovine spongiform encephalopathy (BSE) in cattle and Creutzfeldt-Jakob disease (CJD) in humans are the best known examples (for reviews see : Gajdusek, 1990 ; Esmonde & Will, 1993 ; Goldfarb & Brown, 1995 ; Hart, 1995 ; Carp et al., 1989 ; Diringer, 1992 ; Diringer et al., 1994) . All known TSEs share the common features of long incubation periods, absence of an immune response in the host and an inexorable progression towards death of the affected individual (for review see : Brown, 1990 ). Despite great effort, the causative agent continues to escape identification. The histological hallmarks of TSEs are vacuolation, neurodegeneration and astrocytosis in the central nervous system (CNS) (Fraser, 1979 ; Masters & Richardson, 1978 ; Wells & Wilesmith, 1995) . Another important disease marker is the accumulation of a disease-specific amyloid protein, primarily in the neuropil of infected brains (Bruce et al., 1989 ; Jeffrey et al., 1994) . This the spinal cord : the most important one between thoracic vertebrae T 7-9 , and two minor ones in the lower cervical spinal cord and between vertebrae T 13 -L 2 . Further, strong evidence was found for the existence of a direct route of access to the brain which bypasses the spinal cord and most likely terminates in the medulla oblongata. The indication of an alternative pathway to the brain was confirmed by the data from orally infected hamsters. The spleen appeared to play a potential, but nonessential role in pathogenesis after intraperitoneal infection in our animal model. amyloid protein is derived from a host-encoded, non-amyloid precursor (molecular mass 33-35 kDa) located mainly at the surface of nerve cells. In the literature, the pathological protein is referred to as SAF-protein (Diringer et al., 1983 ; Hilmert & Diringer, 1984) , PrP (protease-resistant or prion protein) (Bolton et al., 1982 ; McKinley et al., 1983) or as TSE-specific amyloid protein (Beekes et al., 1996) . TSE-AP Treatment with proteinase K degrades the cellular TSE-AP precursor protein completely, but converts its native pathological isoform into a protease-resistant core with a molecular mass of 27-30 kDa. While the two isoforms have been extensively characterized, the initial event underlying the conformational change has not yet been elucidated.
While their causative agent remains elusive and the subject of great controversy, investigation of the pathogenetic mechanism of the TSEs has been more fruitful. Studies conducted mainly on scrapie in mice and hamsters have shown that agent uptake is first followed by replication in the lymphoreticular system, mainly the spleen, thymus and Peyer's patches (Fraser & Dickinson, 1970 Ehlers et al., 1984 ; . Most likely travelling along fibres of the autonomous nervous system, for example the splanchnic nerve, the agent then enters the spinal cord between thoracic vertebrae T % and T * and spreads at a rate of about 0n5-1 mm\day (Kimberlin & Walker, 1982 ; Scott & Fraser, 1989 ; Beekes et al., 1996) until it reaches the brain (Kimberlin & Walker, 1979 , 1986 Cole & Kimberlin, 1985 ; . Once the CNS has been affected, replication becomes independent of the lymphoreticular system (Kimberlin & Walker, 1988) . In the brain, the infection continues to progress in a caudal to rostral direction (Kimberlin & Walker, 1982) . The results from two independent experiments, an infectivity-based study in mice (Kimberlin & Walker, 1982) , and a protein-based study performed in hamsters 14 years later (Beekes et al., 1996) , indicated the possibility of a second route of access to the brain beside ascension via the spinal cord. In this paper, we present evidence for an alternative pathway from the periphery to the brain in hamsters after intraperitoneal (i.p.) and oral infection with scrapie.
Methods
Study design. The main part of the study was done in 51 out of 80 outbred Syrian Golden hamsters infected i.p. with scrapie strain 263K. Between 3 and 4 animals each were sacrificed at the following days postinfection (p.i.) : 22, 30, 42, 50, 56, 60, 64, 70, 74, 79, 86, 92 and 98. Additionally, 3 animals showing early clinical symptoms at 106 days p.i. and 3 having already reached the terminal stage of scrapie after 87 and 95 days were sacrificed. Intraperitoneal inoculation was performed by injecting 100 µl of PBS (8 mM Na # HPO % , 1n5 mM KH # PO % , 137 mM NaCl, 2n7 mM KCl, pH 7n4) containing 10 mg of homogenized brain tissue from a hamster in the terminal stage of scrapie into the intraperitoneal cavity. In a second part of the study, 6 hamsters infected 9  22  --------------14  30  --------------16  42  ---4n8  -3n8  4n6  2n7  3n9  4n0  4n1  -4 n 0  0n6  22  50  4n7  3n5  5n5  3n4  4n1  ----4 n 2  5n5  -4 n 4  0n8  27  56  --4n9  5n3  4n9  4n9  -4 n 2  5n3  5n9  5n5  -5 n 1  0n5  32  60  --4n3  5n5  5n8  ---4 n 9  5n9  4n5  5 n 1  5n1  0n6  37  64  5n7  5n9  5n6  5n4  5n2  4n7  3n8  4n0  5n0  5n5  4n6  3 n 7  4n9  0n7  42  70  4n5  5n0  5n5  5n3  5n7  5n0  5n2  5n6  5n4  4n8 orally by feeding each animal 10 mg of homogenized brain tissue (Diringer et al., 1994) Preparation of tissue samples. Hamsters were sacrificed by placing in a CO # atmosphere. The brains, spinal columns and spleens of all animals were removed and immediately fast-frozen in liquid nitrogen. Tissue dissection was performed on the thawed samples 1 day before extraction of TSE-AP. The brains were segmented into the medulla (Me), pons (Po), cerebellum (Ce), cortex (Co) and remaining brain tissue. All of the brain tissue remaining after dissection of the first four brain areas listed was referred to as ' stem ' (St). The spinal cords were dissected into seven segments corresponding to vertebrae :
Spleens were processed as a whole.
Processing of tissue samples, bioassay and quantification of TSE-AP. All samples were homogenized by sonication in TBS (10 mM Tris-HCl, 133 mM NaCl, pH 7n4). Spleens were treated with an Ultra-Turrax homogenizer prior to sonication. Medulla, pons and spinal cord samples (20-70 mg of tissue) were homogenized in 1 ml of TBS. Remaining brain samples of greater weight were homogenized in larger volumes of TBS and subsequently adjusted to a concentration of 100 mg of tissue\ml. Spleen homogenates contained 50-100 mg\ml. TSE-AP was extracted from 1 ml of homogenate according to a protocol established in our laboratory (Beekes et al., 1995) . The proteinase Kresistant core of the protein (molecular mass range 27-30 kDa, 23-25 kDa and 20 kDa) was quantified by densitometry after immunostaining in a Western blot (Beekes et al., 1996) and its concentration in the homogenate was back-calculated (mean errorp0n2 logs). The concentration of cellular TSE-AP precursor protein in the samples from uninfected control animals was assessed directly from the homogenate as described previously (Beekes et al., 1995) . For the i.p. infected hamsters, infectivity titres were determined for each sample from 1 animal sacrificed at 22, 30, 42, 50, 56, 60, 64, 70, 74, 79, 86 and 95 days p.i. The animal sacrificed at 95 days p.i. was in the terminal stage of the disease. The agent titre in the homogenate was assayed (mean errorp0n4 logs) as described by Kimberlin & Walker (1986) using dose-incubation curves (Kimberlin & Walker, 1977 ; Prusiner et al., 1980 Prusiner et al., , 1982 .
TSE-AP as a marker for the disease
(a) Analysis of topographic spread. A study performed recently in this laboratory (Beekes et al., 1996) established a close correlation between infectivity and concentration of TSE-AP in the CNS of hamsters orally infected with scrapie. Based on this relatively constant quantitative relationship between the two disease markers within our animal model, the spread of the pathogenetic process after oral infection was investigated by tracing the accumulation of TSE-AP alone. In the study presented here, the sequential appearance of TSE-AP was used to monitor the spread of the pathogenetic process after i.p. infection. The amount of TSE-AP and the titre of infectivity were assumed to correlate as demonstrated in the previous study, as the animal model and strain of scrapie were kept identical. To be sure, however, the ratio between infectivity titre and the amount of TSE-AP was determined in the samples from 12 animals (see Table 1 ). The topographical spread of the accumulation of TSE-AP throughout the CNS was used as the criterion for grouping the animals into those ' in early stages of incubation ' (see Fig. 2 a, b) and those ' in later stages of incubation ' (see Fig. 2 c) . As the relationship between the period after infection and the accumulation of TSE-AP varied considerably this appeared more appropriate than a ranking simply by the time p.i.
(b) Analysis of accumulation levels. Besides the sequential appearance of TSE-AP further pathogenetic information can be drawn from the quantitative accumulation levels of the pathological protein. This approach is based on the assumption that the relative amounts of TSE-AP in different segments of the CNS reflect the relative duration of the disease process in the respective areas. Studies done previously have shown this to be the case (Muramoto et al., 1992 (Muramoto et al., , 1993 Race & Ernst, 1992) and revealed similar accumulation rates of TSE-AP in the brain and spinal cord of hamsters after oral infection with scrapie except for segment L " -$ , where the accumulation rates were lower than in the remainder of the CNS (Beekes et al., 1996) . In the following, therefore, a relative peak of TSE-AP concentration in any segment of the brain or the spinal cord compared with the neighbouring segments (70) #30 (60) #15 (30): negative for all spinal cord segments #10 (22) #28 (56) #23 (50) #22 (50) #19 (50) #25 ( (64) #18 (42): negative for all brain segments #24 (56) #18 (42) #39 ( #71 (87) #50 (79) #55 (86) #62 (92) #48 (74) #45 (74) #37 (64) #54 (86) #44 (74) #44 (74) #45 (74) #48 (74) #50 (79) #62 (92) #71 ( is interpreted as an indication for an earlier onset of the pathogenetic process. Relative peaks are defined by a difference of at least 0n2 logs (ng of TSE-AP\g of tissue), i.e. exceeding the mean error of TSE-AP quantification, as compared to neighbouring segments.
Results

Correlation of infectivity titre and amount of TSE-AP after i.p. infection
In order to check the correlation of infectivity titre and amount of TSE-AP, all tissue samples from 12 animals sacrificed at different time-points after i.p. infection were assayed for infectivity. In 96 of the 144 CNS samples both infectivity and TSE-AP could be detected and quantified for calculation of the ratio (Table 1 ). The mean ratio between the two disease markers was 4n9 p0n7 [log (LD &! \ng TSE-AP)] in the CNS samples and 4n6 p0n5 [log (LD &! \ng TSE-AP)] in the spleen samples). This corresponded well with the ratio of 4n2 [log (LD &! \ng TSE-AP)] found in a previous study (Beekes et al., 1996) and therefore justified the use of TSE-AP accumulation as the main marker for the progression of the infection, especially as the model system remained identical.
Uninfected controls
A comparison of the concentrations of the cellular TSE-AP precursor protein in all segments of the spinal cord and brain revealed no differences, except for segment T "$ -L # . In T "$ -L # , the concentration of the precursor protein only reached about 20 % of the level in the other segments of the CNS. Therefore, the different concentrations in TSE-AP observed in the course of the infection were not due to differing starting levels of cellular precursor protein.
Evidence for a direct route of access to the brain bypassing the spinal cord after i.p. infection (a) Animals in early stages of incubation. Animals with clearly separated foci of TSE-AP accumulation (Fig. 1) were referred to as animals in the early stages of incubation. Two main patterns were discernible in this group of animals : one with a clearly separated onset of TSE-AP accumulation in the brain and spinal cord (Fig. 2 a) , and one with separate foci in the brain and upper spinal cord on the one hand and in the lower spinal cord on the other (Fig. 2 b) .
First detection of TSE-AP after i.p. infection was possible at the same time in the spinal cord and brain at 22 days p.i. Very often, accumulation of TSE-AP occurred in the lower spinal cord and in some areas of the brain with no pathological protein in the cervical spinal cord adjacent to the medulla oblongata. In two of these cases, the medulla was the only brain segment positive for TSE-AP (Fig. 2 a F30, F40) . One further animal showed accumulation of the pathological protein in the medulla oblongata, pons and stem, with no signal in any part of the spinal cord (Fig. 2 a, F15 ). These patterns of the sequential spread of TSE-AP formation provide strong evidence for the existence of an alternative pathway for the infection to the brain other than by ascension via the spinal cord. The findings shown in Fig. 2 (a) indicate that the medulla oblongata, and possibly the pons, are most likely the first sites of appearance of the pathogenetic process in the brain after entry from the alternative route of access. The peak found in the cerebellum of hamster F22 (Fig. 2 a) possibly points to an alternative pattern of spread in individual animals. However, the observed combinations of affected brain areas in animals with an independent onset of the pathogenetic process in the brain suggest that the infection spreads in a caudal to rostral direction (Table 2) . Peak concentrations found in the brain which were higher than the concentration of TSE-AP in the upper cervical spinal cord (C " -% ) by at least 0n2 logs (ng\g) were considered as an indication for an additional point of entry for the agent into the brain apart from ascension via the spinal cord. Of 15 animals fulfilling this criterion, 10 showed a pronounced peak of TSE-AP accumulation in the medulla. In 4 animals, peaks of the pathological amyloid protein were found in the pons, and in one case distributed over both medulla and pons. The highest concentrations of TSE-AP in the brain of animals in later stages of incubation were never located in the stem, cerebellum or cerebral cortex. This provides further support for an additional route of access to the brain. Medulla and pons appear to be the most likely points of entry, with the pathogenetic process spreading from here to the remaining areas of the brain.
Evidence for entry of the pathogenetic process between thoracic vertebrae T 7 and T 9 after i.p. infection
(a) Animals in early stages of incubation. Only those animals for whom a retrograde spread from the brain or the cervical spinal cord could be excluded were considered in this part of the analysis. This was taken to be the case if there was at least one unaffected segment between the affected parts of the lower thoracic spinal cord and the second cervical segment, or a negative blotting result for either both cervical segments or at least segment C & -( (for examples see Fig. 2 a, b) . In 12 out of 15 animals fulfilling this criterion segment T ( -* was affected. Further, segment T ( -* was positive for TSE-AP in Table 3 . Spinal cord segments with a relative peak of TSE-AP accumulation in later incubation stages after i.p. infection n l 18 animals.
Segment
No. of animals with a relative peak of accumulation in this segment
3 out of 6 animals with only one single positive spinal cord segment. Highest peaking TSE-AP accumulation in the spinal cord [by at least 0n2 logs (ng\g) higher than in the rest of the segments] was located in segment T ( -* in 4 out of 9 animals showing a discernible peak. In 4 other animals, the highest peak spread over both segments T % -' and T ( -* . Taken together, these results strongly point to segment T ( -* as the main point of entry for the infection into the spinal cord from the periphery.
(b) Animals in later stages of incubation. For animals in later stages of incubation (Fig. 2 c) an analysis of accumulation levels was performed as described in Methods. The results are shown in Table 3 . Segment T ( -* appeared as the most frequent site of relative peaks of TSE-AP accumulation (in 12 animals out of 18) and was part of a broader peak extending over T " -T * , T % -T * or T ( -T "# in 3 additional animals (lower part of Table 3 ). These observations provide further evidence for the location of the main spinal point of entry into the CNS in this part of the thoracic cord.
The higher number of relative peaks observed in cervical segment C " -% compared to C & -( indicate an earlier onset of the pathogenetic process in C " -% than in the lower cervical spinal cord in some animals. This could most plausibly be explained by a retrograde infiltration of segment C " -% from the medulla sometimes occurring prior to the onset of TSE-AP accumulation in C & -( .
Possible further points of entry into the CNS after i.p. infection
A closer examination of the two cervical spinal cord segments, C " -% and C & -( , revealed a remarkable pattern of TSE-AP accumulation in some of the animals (Fig. 2 a, F28 ; Fig. 2 b,  F18, F24, F35, F39 ). In all of these cases protein accumulation between vertebrae C " and T $ showed an independent onset with respect to the lower thoracic spinal cord and clearly peaked in the cervical segment C & -( . This indicates a possible additional route of access to the spinal cord.
The occurrence of relative peaks of TSE-AP accumulation in segment T "$ -L # in 4 animals (Fig 2 a, F23, F28 ; Fig. 2 c, F37, F55) could also not be ignored, especially as this segment was an isolated site of TSE-AP accumulation in the spinal cord in 2 animals in early stages of incubation (Fig. 2 a, F10 ; Fig. 2 b,  F24 ). These observations draw additional weight from the fact that the level of the cellular precursor protein in this segment as well as the accumulation rate of TSE-AP is usually particularly low. Thus, there appears to be a third point of entry into the spinal cord between vertebrae T "$ and L # , albeit of lesser importance than the main access between T ( and T * .
Evidence for an alternative route of access to the brain after oral infection
In order to find out whether there are also indications for an alternative pathway for the pathogenetic process to the brain after oral infection, 6 orally infected hamsters taken from a separate study were sacrificed between 82 and 117 days p.i. (Fig. 3) . Four animals of this experimental series were kept until they had reached the terminal stage of scrapie. These hamsters showed early clinical symptoms between 137-155 days p.i.
[mean 145p7 (SEM) days] and terminal symptoms after 145-163 days [mean 155p6 (SEM) days].
The results of the TSE-AP quantification for the 4 animals allowing a differentiation of separate routes of access are summarized in Table 4 . The patterns of TSE-AP formation and the levels of accumulation in the different segments strongly suggest an entry point for the infection into the brain either via the medulla or the pons (F2, F6) . With the results from the study after i.p. infection in mind, the peak of TSE-AP accumulation between C " -C ( in animal F3 is highly suggestive Table 4 . Accumulation of TSE-AP in the CNS of hamsters after oral infection
of agent access via the cervical spinal cord. The accumulation pattern in animal F5 is probably best explained by agent entry into the medulla oblongata and subsequent retrograde spread. Relative peaks of TSE-AP concentration in segment T ( -* and between vertebrae T % -T * correspond well to previous findings (Beekes et al., 1996) . Taken together, the results of the spotcheck examination of orally infected hamsters provide evidence for the existence of an independent access to the brain bypassing the spinal cord also after oral uptake of agent.
TSE-AP accumulation in the spleen after i.p. infection
The concentration of TSE-AP in the spleen varied considerably and showed no correlation with the level of accumulation in any segment of the CNS or with the incubation time. While TSE-AP could be detected in the spleens of 33 out of 51 animals, the spleens of the remaining 18 hamsters were completely negative for the pathological protein. Both groups contained animals from all stages of incubation. TSE-AP was first detected in the spleen at 50 days p.i. The highest concentration (0n1 µg\g) was found at only 56 days p.i. in an animal showing no clinical symptoms.
Appearance of a proteinase K-resistant band in the molecular mass range 33-35 kDa after i.p. and oral infection
An unexpected immunoreactive protein band in the molecular mass range 33-35 kDa was found just above the typical main band of proteinase K-treated TSE-AP (Fig. 1 a-c,  Fig. 3 ). This band appeared only in undiluted samples of the TSE-AP extracts from specimens of animals in early stages of incubation. It could no longer be seen when the level of TSE-AP required sample dilution of 10-, 100-or 1000-fold in order to avoid overloading in the Western blot.
The appearance of the corresponding protein band strongly resembled that of native TSE-AP and its cellular precursor, and treatment with proteinase K did not remove the band. The unknown protein, possibly a proteinase K-resistant folding intermediate between native TSE-AP and its cellular precursor, will be described in more detail in a future paper.
For several reasons, the new band was not included in the quantification of TSE-AP. First, this would require a proper characterization and identification of the protein. Second, the quantification procedure would have had to be modified and validated with a highly purified standard of the new protein, which is not yet available. Third, it has not been established that the new band represents an appropriate marker for infectivity. Thus, for the purpose of the present study, quantification of TSE-AP was performed without modification as described previously (Beekes et al., 1996) , irrespective of the appearance of the new band.
Discussion
Routes of access for the pathogenetic process into the CNS after i.p. and oral infection (a) The brain. The data from this study provide strong evidence for a direct route of access for the scrapie agent from the periphery to the brain which bypasses the spinal cord and most likely terminates in the medulla oblongata. The number of animals in early incubation stages displaying isolated foci of TSE-AP in the brain show that the significance of the alternative route for pathogenesis equals that of the previously established ascent along the spinal cord. A peripheral pathway to the brain was anticipated by Kimberlin & Walker (1982) , who suggested the vagus nerve as a possible route of ascension to the brain. Muramoto et al. (1993) also discussed the possibility of agent entry from the periphery into the brain based on immunohistochemical staining patterns in mice infected with Creutzfeldt-Jacob disease.
The fibres of the vagus nerve appear to be the most likely direct pathway to the brain after i.p. infection, even though a blood-or cerebro-spinal fluid (CSF)-borne access cannot be completely ruled out on the basis of the available data. The fact that the dorsal nucleus of the vagus nerve extends to the border between medulla oblongata and pons may also explain the apparent spread of the first foci in the brain over medulla and pons seen in some cases.
Interestingly, the pathogenetic process manifests itself in the medulla and the lower thoracic cord at about the same time after infection, although the distance from the peritoneum to the lower thoracic cord is shorter than the distance to the medulla oblongata. If the agent does not reach the brain via the blood or CSF, this raises questions concerning a possible direct ascent along the vagus nerve from the peritoneum. Different transport mechanisms for the agent in the vagus and splanchnic nerve might possibly account for the apparently faster mode of travel. A more likely explanation lies in an entry of the agent into the fibres of the vagus nerve not only in the peritoneum, but also at sites closer to the brain. Blood-borne macrophages might carry the agent to organs of the lymphoreticular system outside the peritoneum, such as the thymus. The agent could enter the vagus nerve either from the thymus or possibly even from the cervical lymph nodes or the macrophage reservoir of the lungs. It is interesting to recall that Kimberlin & Walker (1989 b) were able to detect infectivity in the Peyer's patches of the small intestine and in cervical lymph nodes at the same time after intragastric infection.
The sequential appearance of TSE-AP in different areas of the brain as well as the accumulation profiles in later incubation stages strongly suggest a predominant spread of the pathogenetic process in a caudal to rostral direction. An in situ investigation of the pathogenetic process within the brain by immunohistochemical techniques should provide more detailed information and is currently in progress.
The patterns of TSE-AP accumulation observed in the CNS of hamsters infected by the oral route confirmed the evidence for the existence of a direct route of access to the brain also after uptake of agent via the gastro-intestinal tract. As after i.p. infection, the vagus nerve is the most likely route of ascent, if there is no blood-or CSF-borne infection of the brain. However, cranial nerves carrying afferent fibres from the dental roots, the epithelium of the mouth and pharynx or the tongue, such as the trigeminal, facial and glossopharyngeal nerve, may also provide a direct neuronal pathway to the brain after oral infection.
(b) The spinal cord. Evidence for three distinct locations at which the scrapie agent enters the spinal cord after i.p. infection was found in this study. Not surprisingly, the most important entry point lay in thoracic segment T ( -* . The lower thoracic cord has already been described by several authors as a major entry point into the CNS after parenteral, intragastric and oral infection (Kimberlin & Walker, 1979 Cole & Kimberlin, 1985 ; Carp et al., 1994 ; Beekes et al., 1996) . However, the precise entry segment was identified as T ( -* in the present study and as T % -' in the previous study in this laboratory after oral infection (Beekes et al., 1996) . Whether this difference can be attributed to the different routes of infection remains to be investigated. The most likely route of nerve-associated access to this region of the spinal cord is along the sympathetic fibres of the major splanchnic nerve, which was also suggested previously by Kimberlin & Walker (1982 , 1986 . Unexpectedly, two possible minor access sites were found between cervical vertebrae C & and C ( and between thoracic vertebra T "$ and lumbar vertebra L # . These entry points have not been reported before. The direct route from the peritoneum to the lower cervical cord may well lead along the phrenic nerve. The point of entry between T "$ and L # could be reached via the lumbar or pelvic splanchnic nerve.
The role of the spleen after i.p. infection
The data from the present study do not provide a conclusive picture of the role of the spleen in the pathogenesis of scrapie in hamsters after i.p. infection with strain 263K. While detection of TSE-AP in the spleen preceded detection in the CNS in some animals, the spleens of other animals in later or even terminal stages of the disease showed no TSE-AP at all. It appears that the spleen plays a role as a site of agent replication and possibly neural invasion in some animals, but that it is not essential for the development of the disease in our experimental system, other than in different mouse models . This would be in good accordance with earlier studies, which either failed to detect any significant involvement of the spleen in the pathogenetic process after oral infection of hamsters (Beekes et al., 1996) or directly demonstrated disease progression independent of the spleen (Clarke & Haig, 1971 ; .
